Yu Yang Ng

CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts

Yu Yang Ng, Johan Chin-Kang Tay, Shu Wang · Molecular Therapy — Oncolytics · 2019 · 158 citations · Full text

Life Sciences, Immunology, Oncology +17

CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model

Yu Yang Ng, Zhicheng Du, Xi Zhang et al. · Cancer Gene Therapy · 2021 · 94 citations

Medicine, Immunology, Oncology +12

piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells

Zhicheng Du, Yu Yang Ng, Shijun Zha et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 88 citations · Full text

Life Sciences, Immunology, Oncology +17

T Cells Expressing NKG2D CAR with a DAP12 Signaling Domain Stimulate Lower Cytokine Production While Effective in Tumor Eradication

Yu Yang Ng, Johan Chin-Kang Tay, Junjian Wang et al. · Molecular Therapy · 2020 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17

Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts

Wei Xia Ang, Yu Yang Ng, Lin Xiao et al. · Molecular Therapy — Oncolytics · 2020 · 63 citations · Full text

Life Sciences, Immunology, Oncology +17